The three main categories were “heterocyclic compound binding” (89 unigenes in FU like disease resistance protein and 54 unigenes in FD such as ribulose-bisphosphate carboxylase oxygenase activase), “organic cyclic compound binding” (89 unigenes in FU as adp-ribosylation factor 2-like and 54 unigenes in FD such as glycine dehydrogenase) and “hydrolase activity” (64 unigenes in FU such as thaumatin-like protein and 41 unigenes in FD like cysteine proteinase inhibitor) (Figure 1 MF and Tables S1, S2). The gene discussed is ARL2; the disease is Fabry disease.